Dynatronics Corporation
| NASDAQ: DYNT | Healthcare / Medical Devices & Instruments / USA |
| 0.7113 | -0.0238 | -3.24% | Vol 8.96K | 1Y Perf 38.70% |
| Oct 4th, 2023 15:55 DELAYED |
| BID | 0.7101 | ASK | 0.7561 | ||
| Open | 0.6950 | Previous Close | 0.7351 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 2.75 | Analyst Rating | Strong Buy 1.00 | |
| Potential % | 286.62 | Finscreener Ranking | ★★★+ 50.89 | |
| Insiders Trans % 3/6/12 mo. | -/-/100 | Value Ranking | ★★★ 52.02 | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★ 37.81 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/100 | Income Ranking | — - | |
| Price Range Ratio 52W % | 0.92 | Earnings Rating | Strong Sell | |
| Market Cap | 3.03M | Earnings Date | 9th Nov 2023 | |
| Alpha | -0.03 | Standard Deviation | 0.21 | |
| Beta | 0.29 |
Today's Price Range 0.69500.7501 | 52W Range 0.69003.00 | 5 Year PE Ratio Range -3.2023.60 |
Summary:
Neutral
| Technical Indicators: | Buy |
| Moving Averages: | Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | 2.40% | ||
| 1 Month | -3.06% | ||
| 3 Months | -4.97% | ||
| 6 Months | -48.95% | ||
| 1 Year | 38.70% | ||
| 3 Years | 0.51% | ||
| 5 Years | -73.75% | ||
| 10 Years | -76.21% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -11.45 | |||
ROE last 12 Months | -36.30 | |||
ROA (5Y Avg) | -2.55 | |||
ROA last 12 Months | -15.31 | |||
ROC (5Y Avg) | -15.32 | |||
ROC last 12 Months | -28.01 | |||
Return on invested Capital Q | -3.76 | |||
Return on invested Capital Y | -22.79 | |||
Assets Turnover | 0.40 | |||
Receivables Turnover | 2.00 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -1.40 | ||||
| 0.63 | ||||
| 0.25 | ||||
| 54.10 | ||||
| -3.50 | ||||
| -0.21 | ||||
| 4.01 | ||||
| 0.70 | ||||
| 19.00M | ||||
| Forward PE | -2.88 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.70 | ||||
| 1.90 | ||||
| 0.10 | ||||
| 0.26 | ||||
| -34.80 | ||||
| Leverage Ratio | 2.60 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 24.20 | ||||
| -11.00 | ||||
| -7.80 | ||||
| -2.80 | ||||
| -10.55 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 33.56M | ||||
| 1.77 | ||||
| -11.74 | ||||
| 2.70 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q04 2023 | -0.34 | -0.63 | -85.29 |
| Q03 2023 | -0.16 | -0.36 | -125.00 |
| Q02 2023 | -0.15 | -0.27 | -80.00 |
| Q01 2023 | -0.30 | -0.20 | 33.33 |
| Q04 2022 | -0.45 | -0.50 | -11.11 |
| Q03 2022 | -0.45 | -0.45 | 0.00 |
| Q02 2022 | - | -0.45 | - |
| Q01 2022 | - | 0.10 | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 9/2023 QR | -0.26 | 0.00 | - |
| 12/2023 QR | -0.20 | 0.00 | - |
| 6/2024 FY | -0.68 | 0.00 | - |
| 6/2025 FY | -0.26 | 0.00 | - |
| Next Report Date | 9th Nov 2023 |
| Estimated EPS Next Report | -0.20 |
| Estimates Count | 2 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 8.96K |
| Shares Outstanding | 4.26K |
| Shares Float | 2.83M |
| Trades Count | 36 |
| Dollar Volume | 6.39K |
| Avg. Volume | 7.48K |
| Avg. Weekly Volume | 10.07K |
| Avg. Monthly Volume | 5.02K |
| Avg. Quarterly Volume | 7.34K |
Dynatronics Corporation (NASDAQ: DYNT) stock closed at 0.7351 per share at the end of the most recent trading day (a -2.01% change compared to the prior day closing price) with a volume of 16.68K shares and market capitalization of 3.03M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 195 people. Dynatronics Corporation CEO is John A. Krier.
The one-year performance of Dynatronics Corporation stock is 38.7%, while year-to-date (YTD) performance is 88.44%. DYNT stock has a five-year performance of -73.75%. Its 52-week range is between 0.69 and 2.9995, which gives DYNT stock a 52-week price range ratio of 0.92%
Dynatronics Corporation currently has a PE ratio of -1.40, a price-to-book (PB) ratio of 0.63, a price-to-sale (PS) ratio of 0.25, a price to cashflow ratio of 54.10, a PEG ratio of -, a ROA of -15.31%, a ROC of -28.01% and a ROE of -36.30%. The company’s profit margin is -10.55%, its EBITDA margin is -7.80%, and its revenue ttm is $33.56 Million , which makes it $1.77 revenue per share.
Of the last four earnings reports from Dynatronics Corporation, there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.20 for the next earnings report. Dynatronics Corporation’s next earnings report date is 09th Nov 2023.
The consensus rating of Wall Street analysts for Dynatronics Corporation is Strong Buy (1), with a target price of $2.75, which is +286.62% compared to the current price. The earnings rating for Dynatronics Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Dynatronics Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Dynatronics Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 51.20, ATR14 : 0.05, CCI20 : 3.87, Chaikin Money Flow : 0.16, MACD : -0.01, Money Flow Index : 35.52, ROC : 1.29, RSI : 48.44, STOCH (14,3) : 20.50, STOCH RSI : 0.79, UO : 32.72, Williams %R : -79.50), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Dynatronics Corporation in the last 12-months were:
Dynatronics Corporation
Dynatronics Corp is a United States-based company that is engaged in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, rehabilitation equipment, custom athletic training treatment tables and equipment, institutional cabinetry as well as other rehabilitation and therapy products and supplies. The company markets and sells its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions. It offers customers a one-stop-shop for their medical equipment and supply needs, including electrotherapy, therapeutic ultrasound, phototherapy, rehabilitation products, treatment tables, customized training room products, and exercise products.
CEO: John A. Krier
Telephone: +1 801 568-7000
Address: 1200 Trapp Road, Eagan 55121, MN, US
Number of employees: 195
